Hospice Care in Sugar Land, TX
8 Hospice found. Showing 1 - 8
 Gulf Coast Hospice Of Houston Ltd Medicare Approved Location: 134 F Eldridge Rd, Sugar Land, Texas 77478 Phone: (713) 772-2700 |
Altus Hospice Medicare Approved Location: 11352 Sugar Park Lane, Sugar Land, Texas 77478 Phone: (281) 493-9744 |
New Century Hospice Of Houston Medicare Approved Location: One Sugar Creek Center Blvd #330, Sugar Land, Texas 77478 Phone: (281) 277-1151 |
The Providence Hospice Inc Medicare Approved Location: 11420 Dairy Ashford Rd Suite #108, Sugar Land, Texas 77478 Phone: (832) 532-7538 |
Harbor Hospice Of Richmond, Lp Medicare Approved Location: 12808 West Airport Blvd., Suite #335, Sugar Land, Texas 77478 Phone: (281) 762-0444 |
Acura Hospice Care Llc Medicare Approved Location: 13017 Jess Pirtle Blvd Suite 100, Sugar Land, Texas 77478 Phone: (281) 566-1133 |
Hospice Co Medicare Approved Location: 13542 Schumann Tr, Sugar Land, Texas 77498 Phone: (832) 434-2670 |
White Orchid Hospice Llc Medicare Approved Location: 14140 Southwest Freeway Suite 100, Sugar Land, Texas 77478 Phone: (866) 966-2215 |
News Archive
Calif. Senate OKs measure expanding nurse practitioners' role
California lawmakers on Tuesday approved a bill that would allow nurse practitioners to practice more independently amid worries over a shortage of health care providers. The bill would allow the practitioners to have stand-alone practices, among other things.
Engineered HIV vaccine protein may prevent HIV infection
Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" antibodies that can prevent HIV infection.
Elmendorf: Health reform will reduce deficit, warns of fiscal crisis
In remarks to reporters Thursday, Congressional Budget Office director Doug Elmendorf warned of a looming budget crisis that "cannot be solved through minor tinkering." The nation's "unsustainable" spending could increase the national debt from $7.5 trillion at the end of 2009 to 20.3 trillion in 2020, when the debt would total 90 percent of gross domestic product, Elmendorf noted (Allen, 4/8).
APP Pharmaceuticals announces FDA marketing approval of Deferoxamine Mesylate
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
Community insurance co-ops, medical homes offer models for reform
Communities with nonprofit health insurance co-ops or a system of patients having "medical homes' could be useful models in a national health care overhaul.
› Verified 7 days ago